Literature DB >> 6277181

Do calcium-dependent ionic currents mediate ischemic ventricular fibrillation?

W T Clusin, M R Bristow, H S Karagueuzian, B G Katzung, J S Schroeder.   

Abstract

Calcium ions mediate the adverse effects of myocardial ischemia and have been implicated in the genesis of arrhythmias. Calcium influx blocking drugs protect against early ventricular arrhythmias during experimental coronary occlusion, and recent studies suggest that this effect is at least partly due to inhibition of myocardial cell calcium influx. Most of the pharmacologic maneuvers used to simulate acute ischemic arrhythmias in vivo also produce intracellular calcium overload. Production of calcium overload in small myocardial cell clusters causes fibrillatory electrical and mechanical activity similar to that recorded from fibrillating hearts. Fibrillation in these cell clusters is mediated not by reentrant conduction, but by the same subcellular processes that give rise to depolarizing afterpotentials and abnormal automaticity. Agents favoring calcium influx, such as beta adrenergic agonists, accentuate these processes, while agents that depress calcium influx inhibit them. Although the relation of these experimental models to clinical ischemic arrhythmias has not been fully delineated, calcium influx blocking drugs may prove useful in reducing the incidence of sudden cardiac death.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277181     DOI: 10.1016/s0002-9149(82)80019-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Intracellular Ca2+ oscillations drive spontaneous contractions in cardiomyocytes during early development.

Authors:  S Viatchenko-Karpinski; B K Fleischmann; Q Liu; H Sauer; O Gryshchenko; G J Ji; J Hescheler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Intracellular free calcium concentration measured with 19F NMR spectroscopy in intact ferret hearts.

Authors:  E Marban; M Kitakaze; H Kusuoka; J K Porterfield; D T Yue; V P Chacko
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia.

Authors:  Q Timour; B Bui-Xuan; G Faucon; J F Aupetit
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

4.  Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model.

Authors:  E du Toit; D Hofmann; J McCarthy; C Pineda
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

Review 5.  Vasodilator therapy in the perioperative period.

Authors:  P N Fyman; J E Cottrell; L Kushins; P A Casthely
Journal:  Can Anaesth Soc J       Date:  1986-09

6.  Electronic "expression" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells.

Authors:  Glenna C L Bett; Aaron D Kaplan; Agnieszka Lis; Thomas R Cimato; Emmanuel S Tzanakakis; Qinlian Zhou; Michael J Morales; Randall L Rasmusson
Journal:  Heart Rhythm       Date:  2013-09-19       Impact factor: 6.343

7.  Recent trends in the management of life-threatening ventricular arrhythmias.

Authors:  B N Singh; J N Weiss; K Nademanee; J H Wittig; P Guzy
Journal:  West J Med       Date:  1984-11

8.  The possible role of phospholipase A2 in cardiac membrane destabilization under calcium overload conditions.

Authors:  M E Saxon; A K Filippov; U I Porotikov
Journal:  Basic Res Cardiol       Date:  1984 Nov-Dec       Impact factor: 17.165

9.  Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.

Authors:  T Ozaki; T Uematsu; S Nagashima; M Nishimoto; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

10.  Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.

Authors:  J F Aupetit; Q Timour; J P Larbre; J Loufoua-Moundanga; I Kioueh; M Lopez; G Faucon
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.